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Abstract 
 
Aim. To examine the role of 5-HTTLPR, rs25531 and 5-HTT VNTR Intron 2 variants in 
subjects with psychotic disorders manifesting suicide ideation and behaviour.  
 
Methods. The study included 519 subsequently hospitalized subjects who were genotyped for 
5-HTTLPR, rs25531 and 5-HTT VNTR In2 variants. Clinical assessments included structured 
psychiatric interview, sociodemographic characteristics, suicide ideation and behaviour (SIBQ), 
severity of psychopathology (PANSS) and depression (CDSS). 
 
Results. Three subgroups were identified: suicide attempters (N=161), suicide ideators 
(N=174) and subjects who never reported suicide ideation or behaviour (comparative group, 
N=184). Major findings: 1) Suicide attempters scored highest on the CDSS, while no 
differences between the three clinical subgroups were detected in the PANSS scores; 2) Suicide 
attempters were more frequently the carriers of LA allele, while subjects in the comparative 
group were more frequently the carriers of low expression 5-HTTLPR/5-HTT rs25531 
haplotype SLG,; 3) No difference was found between the three clinical groups in the 5-HTT 
VNTR In2 variants; 4) Subjects with 5-HTTLPR/5-HTT rs25531 intermediate expression 
haplotype (LALG, SLA) scored higher on the PANSS general psychopathology subscale; 5) There 
was no association between suicide attempt or ideation and 5-HTTLPR/In2 or 5-
HTTLPR/rs25531/In2 haplotype distribution. 
 
Conclusion. The suicide ideators, attempters and controls did not differ significantly in 5-
HTTLPR or 5-HTT VNTR In 2 variants, but 5-HTTLPR/5-HTT rs25531 haplotype might be a 
useful genetic marker in distinguishing these three clinical groups. 
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1. Introduction 
 
Suicide ideation affects majority of people with schizophrenia, a large proportion of whom 
eventually attempt and complete suicide (De Hert et al., 2001). Today suicide is the leading 
cause of premature death in schizophrenia with approximately 5% completing suicide. (Inskip 
et al., 1998, Palmer et al., 2005).  
 
Findings from the epidemiological genetic studies suggested a genetic origin to substantial 
familial susceptibility both to schizophrenia and suicide behavior (Shih et al., 2004; Brent and 
Mann, 2005). Disturbances in serotonin (5-hydroxitryptamine, 5-HT) transmission are the most 
frequently reported neurobiological substrates of suicide and the gene coding for the serotonin 
transporter (5-HTT) (GenBank accession no. X70697) has been a well-explored candidate for 
genetic studies on suicide. The 5-HTT promoter harbors a functional 43 bp insertion/deletion 
polymorphism (5-HTTLPR), which yields a short and a long allele. The S allele is associated 
with a nearly 50% reduction of basal 5-HTT activity in vitro (Heils et al., 1996) and reduced in 
vivo 5-HTT binding in Caucasians (Praschak-Rieder et al., 2007). Other polymorphisms have 
been found in the proximity of the Ins/Del locus such as rs 25531, rs 25532, rs 2020933. The rs 
25531, a polymorphism nearest to the 5-HTTLPR, results in an A to G substitution and has been 
shown to modulate the effect of 5-HTTLPR on transcription efficacy. The rs 25531 
polymorphism is located immediately outside of the 5-HTTLPR segment, so they can be 
considered as two independent polymorphisms (Bonvicini et al.,2010.). The G allele of rs25531 
is in phase with the 5-HTTLPR long allele and mitigates transcriptional efficacy more than does 
the 5-HTTLPR short allele. Therefore, the modulation of the 5-HTTLPR by rs25531 results in 
haplotypes with high (LA) or low (LG, SA or SG) transcriptional efficacy (Hu et al., 2006; Martin 
et al., 2007). A variable number tandem repeats (VNTR) polymorphism within intron 2 (5-HTT 
VNTRin2) contains 9, 10  (“s”, short allele) or 12 copies (“l”, long allele) of the 16 or 17-base 
pair repeats (Ogilvie and Harmer,1997). Although intron parts of a gene are not transcribed, 
both common repeats  „s“ and „l“ alleles are purported to increase its transcription, with „l“ 
allele having stronger enhancer-like properties than „s“ allele (MacKenzie and Quinn, 1999).  
 
A systematic review of twelve studies with biallelic S/L genotyping demonstrated a higher 
frequency of the low activity S allele  in mood disorders and with suicidal behavior 
(Anguelova
 
et al., 2003). Only one study examined the role of  5-HTTLPR/ rs25531 haplotype  
and 5-HTT VNTR Intron 2 variants in suicide attempters with schizophrenia (De Luca et al., 
2006). De Luca and colleagues genotyped 290 Caucasian subjects with schizophrenia and 
among these patients, 92 had a history of suicide attempt. No association with history of suicide 
attempt was found in the 5-HTTLPR haplotype, but they found significant association with the 
intron 2 VNTR polymorphism, as well as association between suicide attempt and haplotype 
distribution. 
 
The aim of this study is to examine the role of 5-HTTLPR, rs25531, and 5-HTT VNTR Intron 2 
variants in subjects with psychotic disorders who are manifesting suicide ideation and attempts, 
or none of these phenomena. 
2.  Patients and Methods 
 
The study included 519 subsequently hospitalized patients who met the following criteria: (a) 
an ICD-10 diagnosis of psychotic disorder (ICD-10, 1990) and (b) age ≥18 years.  They were 
recruited over the three years period (from 2007. to 2010.) from the Department of Psychiatry, 
University Hospital Center Zagreb. The study protocol was approved by the institutional ethical 
committee and all participants gave written informed consents.  
 
2.1. Patients 
 
Clinical assessments included structured psychiatric interview, collection of sociodemographic 
characteristics, severity of psychopathology (using the Positive and Negative Syndrome Scale, 
PANSS) (Kay et al., 1988), suicide ideation and behaviour (using „Suicide ideation and 
behaviour questionnaire“, SIBQ) (Marušič et al, 2007) and depression using the “Calgary 
Depression Scale for Schizophrenia” (CDSS; Addington, 1990). The latter consists of 14 
questions, divided into two sections. The first section includes ten questions in yes/no format 
assessing suicidality as a dimension that arises from passive to active suicide thoughts, and 
suicide behaviour and attempt. The 10th question is intended for suicide attempters and 
assesses desire for attempting suicide with a 5 points Likert scale (from 1- “I never wanted to 
die” to 5 - “I was determined to die”). The last four questions are related to the family history of 
attempted and completed suicides.  
 
Three subgroups were identified: 
- suicide attempters (group 1), 161 subjects who were admitted after attempting suicide;  
- suicide ideators (group 2), 174 subjects who were admitted for having serious and active 
suicide ideation; and  
- comparative group (group 3), 184 subjects who were hospitalized due to worsening of 
symptoms that was not accompanied by suicide ideation or behaviour at the time of 
admission or ever before 
 
Being aware that patients tend to suppress and distort this information, special attention was 
given to the assessment of suicide ideation and behaviour. Data gathered from the clinical 
interview and SIBQ were double-checked with the medical charts and family members. In 11 
cases SIBQ results indicated that subjects attempted suicide, but interview revealed that they 
took large amount of anxiolytics to calm down and fall asleep, but not to kill themselves (N=6), 
or it was not possible to confirm suicide attempt (N=5). These subjects were excluded and 
analyses were performed on 519 subjects. All ratings were performed at the time of inclusion. 
 
2.2. Genotyping 
 
The DNA was extracted from whole blood with EDTA as described by Miller et al. (1998.). 
The 5-HTTLPR genotyping consisted of two steps – first the “S” and “L” alleles were 
identified, and then the „L” allele was disentangled into “LA” and “LG”. For “S” and “L” allele 
discrimination, we used a method described by Rauch et al. (2002) with our modification 
(Bozina et al. 2007). For the discrimination of the “LA” and “LG” structure, specific fluorogenic 
probes were used in real time polymerase chain reactions method based on a procedure 
described by Hu et al. (2006) with our modification: the 25 µl reaction volume contained 15 ng 
of genomic DNA, 12.5 µl of Taqman master Mix (Applied Biosystems), and 5µl of Assay Mix 
that contained 2.5 µM of each primer, 3 µM of LA probe, 2µM of LG probe and 1 µl of 4% 
DMSO. Amplification was performed in a 7500 Real Time PCR System in 96 –well plates 
under the following PCR conditions: 50°C for 2 min and 95°C for 10 min, followed by 40 
cycles at 96°C for 15 sec and 62.5°C for 1min 30 sec. In order to acquire reliable controls and 
to check some questionable results, we performed genotype sequencing (3130 x l Genetic 
Analyzer, Applied Biosystems), also based on a previous study (Hu et al., 2006). Furthermore, 
in order to double check the real time PCR method, every tenth sample was genotyped 
according to the published PCR-RFLP methods (Lonsdorf et al., 2009). 5-HTT VNTR Intron 2 
analysis was performed according to a method described previously (Ito et al., 2002).  
 
2.3. Data analysis 
 
The statistical analysis was performed using SPSS for Windows version 15 (SPSS Inc., 
Chicago, IL, USA). Study subjects were described using means and standard deviations for 
interval measures and frequencies and percentages for categorical variables. For testing the 
normality of data distribution, Kolmogorov–Smirnov goodness of fit test was used (with p>0.05 
considered as a non-significant departure from normality). Chi-square tests were used to 
compare the groups for different categorical variables, including allele and genotype 
frequencies. Analyses of variance were used for comparison of normally distributed interval 
variables and Kruskal-Wallis H test and Mann-Whitney U test were used in case of non-normal 
distributionsand. Statistical hypotheses were tested at alpha error rate set to 0.05, except in three 
post-hoc paired comparisons between groups where alpha error rate for each contrast was 
lowered to 0.017 according to the Bonferroni adjustment.  The equivalence of the genotype 
distribution to the Hardy-Weinberg equilibrium was tested using the online software 
(http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). In addition, haplotype based analysis 
of the associations of genetic polymorphic variants of the SERT gene and PANSS scores and 
the suicide behaviour-groups were tested using program UNPHASED ver. 3.0.10 (Dudbridge, 
2003) and Arlequin ver. 3.01 (Excoffier et al., 2006), respectively. 
 
The power analysis was performed with the use of G* Power3 (release 3.1.3 for Windows XP, 
2011) (Faul et al., 2007, 2009). This study had a power of 0.353 to detect a small effect size 
(0.10, alpha=0.017), 0.999 to detect a medium effect size (0.30, alpha=0.017) and 1.0 to detect 
a large effect size (0.50, alpha=0.017) in the biallelic genotype distribution and the expression-
groups genotype distribution (N=519); and a power of 0.256 to detect a small effect size (0.10, 
alpha=0.017), 0.999 to detect a medium effect size (0.30, alpha=0.017) and 1.0 to detect a large 
effect size (0.50, alpha=0.017) in the 5-HTTLPR/rs25531 haplotypes distribution (N=519). For 
the allele frequency analysis (N=1038) the study had a power of 0.797 to detect a small effect 
size (0.10, alpha=0.017), 1.0 to detect a medium effect size (0.30, alpha=0.017), and 1.0 to 
detect a large effect size (0.50, alpha=0.017). Effect size conventions were determined 
according to the method of Buchner et al. (1997). 
 
3. Results 
 
3.1. Differences in general characteristics  
  
The descriptive statistics for the entire sample (column All) and for each of the three clinical 
subgroups are shown in Table 1. The Kruskal-Wallis H test showed that subjects differed 
statistically significantly with regard to age. The post-hoc Mann-Whitney U test showed that 
suicide ideators were significantly younger than the comparative group (p = 0.001), whereas 
attempters did not differ in age from the comparative group nor from the ideators. The 
percentage of women differed between the groups, being the highest in the comparative group 
(adjusted standardized residual for group 1 was –3.1, for group 2 it was –1.8, and for group 3 it 
was 4.7). The comparative group also had the highest percentage of subjects with university 
degree (adjusted standardized residual for group 1 was –2.1, for group 2 it was –0.2, and for 
group 3 it was 2.3). The three groups did not differ significantly in terms of marital status, 
parenthood, type of psychotic disorder or family history. The percentage of subjects who were 
retired due to mental illness (n=40, i.e. 24.8% of group 1, adjusted standardized residual = 3.6) 
was statistically significantly higher among suicide attempters than among the ideators (n=25, 
14.4%, adjusted standardized residual = –0.8) or the comparative group (n=19, 10.3%, adjusted 
standardized residual = –2.7), χ
2
=13.98, df=2, p=0.001.  
  
3.2 Symptomatic profile  
 
The psychopathology was assessed using PANSS and results for the entire sample show that 
the mean positive subscale score was 26.67 (SD=7.11), negative subscale score 22.68 
(SD=6.91), general psychopathology subscale score 52.78 (SD=8.82) and total PANSS score 
was 102.14 (SD=16.5). ANOVAs revealed no statistically significant difference among the 
three clinical subgroups when these scores were compared (for positive subscale F=2.93, df1=2, 
df2=512, p=0.054; for negative subscale F=0.29, df1=2, df2=512, p=0.747; for general 
psychopathology F=1.67, df1=2, df2=511, p=0.190). The suicide attempters scored highest on 
the Calgary Depression Scale for Schizophrenia (CDSS) – mean score was 10.4 (SD=6.5), 
while scores in the suicide ideation group and the comparative group were 8.7 (SD=6.4) and 4.3 
(SD=5.1), respectively (Kruskal-Wallis χ
 2
=82.57, df=2, p<0.001). 
 
 
3.3. Serotonin transporter 
 
3.3.1. The 5-HTTLPR biallelic structure 
 
Looking at the biallelic structure of the 5-HTTLPR polymorphism, the genotype frequencies in 
the entire sample (see the first column of Table 2) did not differ significantly from the Hardy-
Weinberg equilibrium, χ
2
=1.49, df=2, p=0.220. There was also no significant difference in the 
frequencies among the three subclinical groups (see the second, third and the fourth columns of 
Table 2 for the frequencies). The LL genotype was more frequent among suicide attempters, but 
the difference did not reach statistical significance (χ
2
=4.953, df=2, p=0.084). 
 
 
3.3.2. The 5-HTTLPR/rs25531 haplotype 
 
The triallelic structure of the 5-HTTLPR polymorphism indicated five haplotypes:, LA/LA, 
LA/LG, S/LA S/LG, S/S (see Table 2 for frequencies). Out of all “L” alleles, 6% were “LG“ alleles 
which would be considered as “L” alleles in the biallelic structure, but their function is much 
closer to the “S” alelles. The “LA“ allele was significantly more frequent among suicide 
attempters than in the other two groups (χ2=6.487, df=2, p=0.039). Data are given in Table 2. 
 
3.3.3. The 5-HTTLPR expression groups 
 
The next step was to group the 5-HTTLPR/rs25531 haplotypes according to their expression 
into “high expression” (LA/LA), "intermediate expression” (LA/LG and S/LA) and “low 
expression” (S/LG and S/S) genotypes. The frequencies were: 139 (0.27), 276 (0.53) and 104 
(0.20), respectively. The three clinical groups differed with respect to the frequency of “low 
expression” genotypes which was more frequent in the comparative group (0.24) than in the 
other two groups (0.14 in group 1,  0.22 in group 2, χ
2
=6.58, df=4, p=0.143), but it was not 
statistically significant.  
 
3.3.4. The 5-HTT VNTR Intron 2 variants 
 
The 5-HTTVNTR-In2 frequencies for the entire sample (see the first column in Table 3) did not 
differ from the Hardy-Weinberg equilibrium (χ2=1.31, df=2 p=0.253). There was no difference 
between the three clinical groups in the genotype frequencies or with regard to allele 
frequencies. Only four subjects were genotyped with 9 copies (all with suicide ideation). They 
were merged with subjects with 10 copies (9+10) in the further analysis. Data are given in 
Table 3. 
 
3.3.5. Haplotype analysis - 5-HTTLPR/In2 and 5-HTTLPR/rs25531/In2 
 
The haplotype analysis of the 5-HTTLPR/In2 and 5-HTTLPR/rs25531/In2 showed no 
significant differences between the three clinical groups. Data shown in Table 4. 
 
 
3.4. Association between the examined genetic variants and subjects’ psychopathology 
 
We found statistically significant difference between the 5-HTTLPR expression groups and 
PANSS general psychopathology subscale (Table 5). Subjects with the 5-HTTLPR intermediate 
expression haplotypes (LA/LG, S/LA) scored higher than both high-expression and low-
expression group (F=3.89, df1=2, df2=513, p=0.021). Other comparisons did not reach the level 
of statistical significance. Furthermore, poor attention (PANSS item G11) was associated with 
both 5-HTTLPR/In2 and 5-HTTLPR/rs25531/In2 haplotypes (χ2=10.86, df=3, p=0.0125; 
χ
2
=12.68, df=5, p=0.0265). The combination of “S” and “s” alleles was associated with lower 
scores on poor attention in 5-HTTLPR/In2 analysis (AddVal -0.159, CI -0.385 - 0.067, specific 
test χ
2
=4.059, p=0.043) and higher in 5-HTTLPR/rs25531/In2 analysis (AddVal 0.4047, CI -
0.053 - 0.824, specific test χ
2
=3.896, p=0.048). However, those associations did not remain 
statistically significant after Bonferroni corrections. The stereotyped thinking (N7 item) was 
associated with 5-HTTLPR/In2 haplotype only with the borderline significance (χ2=7.439, df=3, 
p=0.057). The combination of “S” and “s” alleles was associated with higher scores on 
stereotyped thinking (AddVal 0.2571, CI 0.078 - 0.4364; specific test χ
2
=6.567, p=0.0103). 
 
4. Discussion 
 
Our findings indicate that suicide ideators and attempters with psychotic disorders can be 
distinguished from the comparative group of subjects with psychotic disorders who do not 
express suicide ideation, nor have ever attempted suicide, on both clinical and biological level.  
 
The three clinical groups did not differ significantly in 5-HTTLPR – biallelic variant, however, 
looking at the 5-HTTLPR/rs25531 haplotype offers an entirely different perspective on the 
matter. Suicide attempters were more frequently carriers of „LA“ allele, while subjects in the 
comparative group were more frequently carriers of lower expression haplotypes (S/LG, S/S). 
Only two studies reported higher frequencies of „L“ allele among subjects who completed 
suicide. Du and colleagues analyzed a functional polymorphism in the 5' regulatory region of 
the 5-HT transporter gene from postmortem brain samples of 24 depressed suicide victims and 
31 control subjects and found significantly higher frequencies of „L“ allele among depressed 
subjects (Du et al., 1999). This finding appears to be in accordance with the  monoamine 
hypothesis of lower availability of serotonin as a key feature of depression. In the second study, 
95 suicides and 120 healthy controls were compared and the first were characterized with 
higher frequency of „L“ allele, but the difference did not reach the level of statistical 
significance (Fitch et al., 2000). However, as previously mentioned, most of the studies in the 
field detected higher frequency of „S“ allele which was associated with anxiety (Lesch et al., 
1996) and aggression (Sander et al., 1998). Results from our population (subjects of Croatian 
origin) suggest modest association between „L“ and „s“ allele in suicide cases (of unknown 
psychiatric history) in comparison to healthy population (Hranilovic et al., 2000). Altogether, 
there is still a small number of studies with 5-HTTLPR/rs25531 haplotype. One of the first in 
suicidology, published by Zalsman and colleagues, explored 191 subjects with mood disorder 
and 125 healthy volunteers, and reported that lower expressing transporter alleles, 
independently predicted greater depression severity and predicted greater severity of major 
depression with moderate to severe life events compared with the higher expressing LA allele, 
but no associations with suicidal behavior was found (Zalsman et al., 2006). Similarly, we also 
showed that lower expressing alleles are not associated with sucide ideaion or attempts. As 
already mentioned, De Luca and colleagues found no association between the 5-
HTTLPR/rs25531 haplotype and suicide attempts in schizophrenia (De Luca et al., 2006). 
However, they did find significant association with the intron 2 VNTR polymorphism. Our 
study is quite comparable in methodology to this one as we also used positive controls (and not 
healthy subjects), but results are different as we found no difference between the three clinical 
groups in the 5HT In2 VNTR genotype and allele frequencies. Interestingly, we found only 
four alleles with 9 copies within the intron 2 VNTR polymorphism which represents the 
frequency of 0.4%. In another study performed among the Croatian population, authors 
reported that this allele was present in 1% of the healthy controls, and 2% of suicide 
victims. This allele seems to be rare in other European Caucasian populations (healthy 
controls) as well – English 3%, French and german 1%, Scottish 1%, Spanish 2% (Cho et 
al., 2005).  
 
Suicide attempters in our study scored significantly higher on PANSS scale assessing general 
psychopathology. They also scored higher on depression. It could be argued that suicide 
behaviour in schizophrenia does not emerge from psychotic symptoms such as hallucinations 
and delusions, but rather from depressive mood (Cotton et al., 1985; Strosahl et al., 1992, 
Acosta et al., 2006), agitation (Hawton et al., 2005) and insight into illness (Kim et al., 2003). 
Depression and insight into illness together might lead to hopelessness which is an extremely 
dangerous suicide risk factor.  
 
Suicide ideators were younger than other study participants. This is in accordance with previous 
findings that suicide risk changes with time and suicide ideation occurs mostly early in the 
course of illness (Palmer et al., 2005; Nordentoft et al., 2004). Suicide ideators and attempters 
were mostly men with lower level of education and retired due to illness. The two 
characteristics (male gender and education) are also well known suicide risk factors, and early 
retirement might be an indicator of poor social functioning and more significant 
psychopathological burden which might have a negative impact on quality of life and desire to 
continue living.  
 
Study's main limitation is a cross-sectional design, and the strength, in our opinion, is in using 
positive controls, not healthy ones. From the point of someone who works in psychiatric 
clinical practice and deals exclusively with subjects with schizophrenia, it seems to be crucial 
(for both diagnostics and treatment) to find differences within this very population, not in 
comparison with healthy people. We believe that our results might add on attempts to integrate 
clinical and genetic data. 
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Table 1 – Study sample 
 
 
All 
(N = 519) 
Group 1 –  
SA 
(N = 161) 
Group 2 –  
SI 
(N = 174) 
Group 3 – 
Comparative 
(N = 184) 
Test of differences  
among groups 
Age M (SD) 33.7 (11.3) 33.3 (11.3) 31.7 (11.9) 35.9 (11.7) 
Kruskal-Wallis χ
 2
=10.55,  
df=2, p=0.005 
Age at illness onset M (SD) 28.2 (10.0) 28.0 (9.7) 27.6 (10.4) 29.1 (9.7) 
Kruskal-Wallis χ
 2
=4.64,  
df=2, p=0.098 
Type of psychosis N (%)     χ
 2
=8.92, df=10, p=0.540 
paranoid schizophrenia 376 (72.4) 108 (67.1) 127 (73.0) 141 (76.6)  
disorganized schizophrenia 43 (8.3) 15 (9.3) 14 (8.0) 14 (7.6)  
residual schizophrenia 17 (3.3) 9 (5.6) 4 (2.3) 4 (2.2)  
other schizophrenia 14 (2.7) 3 (1.9) 7 (4.0) 4 (2.2)  
persistent delusional disorder 27 (5.2) 11 (6.8) 9 (5.2) 7 (3.8)  
schizoaffective disorder 42 (8.1) 15 (9.3) 13 (7.5) 14 (7.6)  
Family history N (%)     χ 2=5.55, df=4, p=0.235 
psychosis 131 (25.2) 40 (25.3) 47 (27.6) 44 (24.9)  
other mental illness 141 (27.2) 49 (31.0) 52 (30.6) 40 (22.6)  
negative family history 233 (44.9) 69 (43.7) 71 (41.8) 93 (52.5)  
Women N (%) 278 (53.6) 71 (44.1) 84 (44.3) 123 (66.8) χ
 2
=20.81, df=2, p<0.001 
Education N (%)     χ
 2
=17.02, df=6, p=0.028
a
 
no formal education 9 (1.7) 5 (3.1) 1 (0.6) 3 (1.6)  
primary school 54 (10.4) 22 (13.7) 20 (11.5) 12 (6.5)  
high school  328 (62.2) 106 (65.8) 105 (60.3) 117 (63.6)  
university student 53 (10.2) 13 (8) 23 (13.2) 17 (9.3)  
university degree 75 (14.4) 15 (9.3) 25 (14.4) 35 (19.02)  
Marital status N (%)     χ
 2
=4.51, df=4, p=0.607
b
 
single 315 (60.7) 97 (60.2) 113 (64.9) 105 (57.1)  
married 162 (31.2) 49 (30.4) 53 (30.5) 60 (32.6)  
divorced 35 (6.7) 12 (7.5) 7 (4.02) 16 (8.7)  
widow 4 (0.7) 1 (0.6) 1 (0.5) 2 (1.08)  
 2
Parenthood N (%)  192 (36.9) 60 (37.3) 57 (32.8) 75 (40.8) χ 
2
=2.737, df=2, p=0.259 
Employment status N (%)     χ 
2
=14.079, df=4, p=0.007 
employed 171 (32.9) 43 (26.7) 60 (34.5) 68 (36.9)  
unemployed 251 (48.3) 73 (45.3) 85 (48.9) 93 (50.5)  
retired 94 (18.1) 43 (26.7) 29 (16.7) 22 (11.9)  
 
Note: SA stands for subjects who attempted suicide, SI stands for subjects who reported suicide ideation, Comparative 
stands for subjects without suicide attempt or ideation.  a“No formal education“ was merged with „primary school“ due to theoretical 
frequencies less than 5. b Category „widow“ was merged with „divorced“ due to theoretical frequencies less than 5. 
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 Table 2 - 5-HTTLPR/rs25531 allele, genotype and haplotype frequencies 
 
SEROTONINE TRANSPORTER 
 
All 
 
(N = 519) 
Group 1 – 
SA 
(N = 161) 
Group 2 – 
SI 
(N = 174) 
Group 3 – 
Comparative 
(N = 184) 
 
Test of differences 
 among groups 
5-HTTLPR      
Genotype     χ
2
=5.012, df=4, p=0.286 
L/S 250 (0.48) 82 (0.51) 82 (0.47) 86 (0.47)  
L/L 183 (0.35) 61 (0.38) 60 (0.35) 62 (0.34)  
S/S 86 (0.17) 18 (0.11) 32 (0.18) 36 (0.19)  
Alelle     χ
2
=4.995, df=4, p= 0.082 
L allele 616 (0.59) 204 (0.63) 202 (0.58) 210 (0.57)   
S allele 422 (0.41) 118 (0.37) 146 (0.42) 158 (0.43)  
5-HTTLPR/rs25531      
Haplotype     χ
2
=7.534, df=8, p=0.480 
S/LA 232 (0.44) 78 (0.48) 76 (0.44) 78 (0.42)  
LA/LA 139 (0.27) 44 (0.27) 47 (0.27) 47 (0.26)  
LA/LG 44 (0.08) 17 (0.11) 13 (0.08) 14 (0.08)  
S/LG 19 (0.04) 4 (0.02) 6 (0.03) 9 (0.05)  
S/S 85 (0.17) 18 (0.11) 32 (0.18) 36 (0.19)  
Allele     χ
2=6.487, df=2, p=0.039 
LA 554 (0.53) 183 (0.57) 183 (0.53) 186 (0.51)  
S + LG 484 (0.47) 139 (0.43) 163 (0.47) 182 (0.49)  
5-HTTLPR/rs25531 
expression groups    
 χ
2
=6.58, df=4, p=0.143 
high expression (LA/LA) 139 (0.27) 44 (0.27) 47 (0.27) 47 (0.26)  
intermediate expression (LA/LG, S/LA) 276 (0.53) 95 (0.59) 89 (0.51) 92 (0.50)  
low expression  (S/LG, S/S) 104 (0.20) 22 (0.14) 38 (0.22) 45 (0.24)  
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Table 3 - 5-HTTVNTR-In2 allele and genotype frequencies 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: SA stands for subjects who attempted suicide, SI for subjects who reported suicide ideation, Comparative stands for 
subjects without suicide attempt or ideation.   
* Since only 4 alleles with 9 copies were genotyped (all in subjects with suicide ideation), they were grouped with alleles with 
10 copies for the further analysis (9+10) 
 
 
 
 
 
 
 
SEROTONINE 
TRANSPORTER 
 
All 
 
(N = 519) 
Group 1 – 
SA 
(N = 161) 
Group 2 – 
SI 
(N = 174) 
Group 3 – 
Comparative 
(N = 184) 
Results of statistical tests for 
comparison  
of the three groups 
5-HTT Intron2 VNTR       
Allele     χ
2
=2.694, df=2, p=0.260 
 12  648 (0.63) 193 (0.60) 229 (0.66) 226 (0.61)  
 9+10 * 390 (0.37) 129 (0.40) 119 (0.34) 142 (0.39)  
Genotype     χ
2
=5.037, df=4, p=0.284 
12/9+10 232 (0.45) 67 (0.42) 75 (0.43) 90 (0.49)  
 12/12 208 (0.40) 63 (0.39) 77 (0.44) 68 (0.37)  
 9+10/9+10  79 (0.15) 31 (0.19) 22 (0.13) 26 (0.14)  
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Table 4  - Haplotype analysis,  5-HTTLPR/In2 and 5-HTTLPR/rs25531/In2 
 
 
Haplotype Frequencies 
 
Haplotype 
 
Group 1 – 
SA 
(N = 161) 
Group 2 – 
SI 
(N = 174) 
Group 3 – 
Comparative 
(N = 184) 
5-HTTLPR/In2*    
L, 12 0.194 0.193 0.187 
L, 9+10 0.239 0.245 0.248 
S, 12 0.292 0.31 0.243 
S, 9+10 0.275 0.252 0.322 
5-HTTLPR/rs25531/In2*    
LA, 12 0.246 0.217 0.188 
LG, 12 0.038 0.028 0.025 
S, 12 0.204 0.257 0.233 
LA, 9+10 0.319 0.314 0.319 
LG, 9+10 0.029 0.027 0.039 
S, 9+10 0.164 0.157 0.203 
 
Note: * Results of statistical tests for comparison of the three groups in 5-HTTLPR/In2 and 5-HTTLPR/rs25531/In2 analysis p=n.s. 
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Table 5 – Means (and standard deviations in parentheses) for subjects’ psychopathology and depression in different  
5-HTTLPR/rs25531 expression groups 
 
Scale 
High 
expression 
(LA/LA) 
(N=139) 
Intermediate 
expression 
(LA/LG, S/LA) 
(N=276) 
Low 
expression 
(S/LG, S/S) 
(N=104) 
 
 
 
Test of differences among groups 
PANSS – Positive symptoms 26.14 (7.52)  26.95 (6.98) 26.68 (7.10) F=0.59, df1=2, df2=512, p=0.557 
PANSS – Negative symptoms 23.02 (6.81) 23.04 (6.81) 21.60 (7.22) F=1.59, df1=2, df2=512, p=0.204 
PANSS – General psychopathology 51.61 (9.31) 53.75 (8.50) 51.54 (8.88) F=3.89, df1=2, df2=511, p=0.021 
PANSS – Total score 100.77 (17.62) 103.74 (15.90) 99.83 (16.30) F=2.78, df1=2, df2=511, p=0.063 
CDSS 8.38 (6.73) 7.56 (6.46) 7.12 (6.46) Kruskal-Wallis χ
2
=2.38, df=2, p=0.304 
 
Note. PANSS stands for “Positive and Negative Symptoms Scale“. CDS stands for “Calgary Depression Scale for Schizophrenia”. 
 
 
 
 
